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Therapeutic hypothermia (TH) for neonatal hypoxic-ischaemic encephalopathy (HIE), 
delivered mainly in tertiary cooling centres (CCs), reduces mortality and 
neurodisability. It is unknown if birth in a non-cooling centre (non-CC), without active 
TH, impacts short-term outcomes. 
Design 
Retrospective cohort study using National Neonatal Research Database and 
propensity score-matching. 
Setting 
UK neonatal units. 
Patients 
Infants 36 weeks gestational age with moderate or severe HIE admitted 2011-2016. 
Interventions 
Birth in non-CC compared to CC. 
Main outcome measures 
Primary outcome was survival to discharge without recorded seizures. Secondary 
outcomes were recorded seizures, mortality and temperature on arrival at CCs 
following transfer. 
Results 
5059 infants were included with 2364 (46.7%) born in non-CCs. Birth in a CC was 
associated with improved survival without seizures (35.1% vs 31.8%; OR 1.15, 95% 
CI 1.02-1.31; p=0.02), fewer seizures (60.7% vs 64.6%; OR 0.84, 95% CI 0.75-0.95, 
p=0.007) and similar mortality (15.8% vs 14.4%; OR 1.11, 95% CI 0.93-1.31, p=0.20) 
compared with birth in a non-CC. Matched infants from level 2 centres only had 
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similar results, and birth in CCs was associated with greater seizure-free survival 
compared to non-CCs.  Following transfer from a non-CC to a CC (n=2027), 1362 
(67.1%) infants arrived with a recorded optimal therapeutic temperature but only 259 
(12.7%) of these arrived within six hours of birth. 
Conclusions 
Almost half of UK infants with HIE were born in a non-CC, which was associated with 
suboptimal hypothermic treatment and reduced seizure-free survival. Provision of 






































Moderate or severe hypoxic ischaemic encephalopathy (HIE) is the leading cause of 
mortality and neurodisability in infants 36 weeks gestational age (GA) affecting an 
estimated 1.5 - 2.0/1000 births.1 2 Active therapeutic hypothermia (TH) commenced 
within the first six hours post insult is safe 3 4 and significantly improves survival and 
neurodisability. 5 6 Active TH for moderate/severe HIE has been successfully 
established within regional cooling centres (CCs), 7 that are mainly tertiary neonatal 
centres in the UK. Infants born in non-cooling centres (non-CCs), typically non-
tertiary centres where equipment to undertake active TH is not available, are usually 
passively cooled prior to upward transfer to a regional CC. Although many neonatal 
transport teams use active TH during transportation,8 their availability, despatch time 
and travelling distance can delay achieving target temperature for babies in non-CCs 
with delays beyond six hours of age could reduce the benefits of TH.9 Furthermore, 
early TH (<3 hours of age) has been associated with better neurodevelopmental 
outcomes 9 10 although not universally.11 12 
 
High seizure burden in HIE, based on their number, frequency and treatment 
required, is associated with more severe brain injury and adverse 
neurodevelopmental outcomes 13-18 and this may be independent of HIE severity.15 19 
Furthermore, studies have suggested that TH for HIE suppresses and reduces the 
overall burden of seizures,6 13 20 21 leading some to conclude that seizures 
exacerbate the underlying brain injury and is potentially one of the mechanisms by 
which TH protects the brain.21 22 Parents of infants with seizures associated with HIE  
have more mental health problems with symptoms of anxiety and depression.23 
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Centralisation of CCs has resulted in many infants requiring transportation soon after 
their insult and potentially during a period of increased susceptibility to secondary 
brain injury. It is unclear if the transport of newborns with HIE impacts on their 
outcomes.24 No study has explored the impact of a nationwide approach to 
centralised TH for infants with HIE and the impact on outcomes. 
 
The primary aim of this study was to evaluate the relationship between birth in a non-
CC and seizure-free survival to discharge in infants 36 weeks GA with 
moderate/severe HIE. The secondary aims were to compare mortality, seizures only 






We performed a retrospective cohort study using the validated UK National Neonatal 
Research Database (NNRD).25 The NNRD contains prospectively recorded 
demographic and clinical data. It uses a designated approved dataset (National 
Neonatal Data Set) within the NHS Data Dictionary with all data items searchable 26 
and approved by the Standardised Committee for Care Information. Anonymised 
data is cleaned prior to entry into the database; erroneous entries are amended by 




Data were extracted on all infants 36 to 42 weeks’ GA, admitted to neonatal units in 
the UK between 2011 and 2016, with a diagnosis of moderate/severe HIE and 
underwent TH. Infants who died within the first 48 hours of life with moderate/severe 
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HIE but did not undergo TH, were also included within the study population. Infants 
were identified using data fields from the NNRD (Supplementary Table 1); the most 
severe grade of HIE recorded was allocated for each infant. Infants were excluded if 
their birth weight was >2 standard deviations above the 99.6th weight centile (to 
avoid erroneous data, n=5), those born in private hospitals or with missing birth 
hospital codes. Identification of CCs and their date of active TH commencement, 




The primary outcome was seizure-free survival to neonatal discharge in infants 36 
weeks GA with moderate/severe HIE. Seizures were as recorded by the attending 
clinical team within the database. Secondary outcomes were mortality, seizures 
alone, anticonvulsant use and admission temperature from time of birth to arrival at a 
CC following transfer. 
 
Statistical Analysis 
Clinical variables between infants born in non-CCs and CCs were compared using 
chi-squared test for categorical data and Mann-Whitney U test for non-normally 
distributed data.  
 
Propensity score-matching was used to provide balanced groups of infants matched 
on demographic and clinical covariates within treatment groups.27 28 Propensity score 
analysis entailed fitting a logistic regression model using a priori variables followed 
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by a stepwise process and evaluation of potential interactions to determine 
covariates to include in the propensity score model (Supplementary eMethods).  
Balancing of the groups post-matching was evaluated by the standardised difference 
and mean bias between control and treatment groups (Supplementary eMethods, 
Supplementary Fig. 1 and Table 1).29 30 Matched groups of infants from non-CC and 
CC were identified and the effect of birth in a CC on outcomes was described using 




We performed two further paired, matched analyses between infants born in level 2 
non-CCs and CCs and between infants born in a non-CC and CC but excluding 
those born either at home or in midwife led units. The propensity matching 
methodology was undertaken as previously described (Supplementary eMethods, 
Supplementary Figure 2 and 3). These additional analyses were performed to 
evaluate the reliability of our findings by minimising potential bias through differences 




There were 5120 infants 36 weeks GA admitted to UK neonatal units with 
moderate/severe HIE and treated with TH. An additional 127 infants with 
moderate/severe HIE died within the first 48 hours of life without TH treatment were 
also included. In total, 188 infants were excluded (Supplementary Figure 1) leaving 
5059 infants for analysis. Prior to matching, 2364 (46.7%) infants were born in a non-
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CC (Table 1). In the unmatched groups, 65.4% of infants in the non-CC group were 
born in level 2 units; 71.9% of  CC infants were born in a level 3 unit.  
 
Propensity matched groups 
Propensity score-matching (Supplementary Figure 2) yielded a total of 4330 infants 
(n=2165/group, Table 1). Infants born in a CC had significantly higher rates of 
seizure-free survival prior to discharge compared to infants born in a non-CC (35.1% 
vs 31.8%; OR 1.15, 95% CI 1.02–1.31; p=0.02) and significantly lower odds of 
recorded seizures overall (60.7% vs 64.6%; OR 0.84, 95% CI 0.75-0.95; p=0.007). 
Mortality prior to discharge was similar between the groups (Table 2). 
 
In matched infants, 76.2% (n=2068) of infants recorded as having seizures received 
anticonvulsant medication, 27.1% of these infants received escalation of treatment 
with additional anticonvulsant agents but there was no difference between groups 
(Table 2). Compared to CC infants, those born in a non-CC received similar amounts 
of cardiorespiratory support but did require a longer length of hospital stay (Table 2). 
 
Level 2 births only 
Propensity score-matching yielded 1392 infants (n=696/group, Table 3 and 4, 
Supplementary Figure 3). Matched infants born in a level 2 CC had significantly 
higher seizure-free survival (38.8% vs 32.3%; OR 1.33, 95% CI 1.06-1.65; p=0.01), 
less recorded seizures (57.6% vs 63.9%; OR 0.77, 95% CI 0.61-0.95; p=0.02), and 
fewer anticonvulsants compared to infants born in level 2 non-CC. Mortality was not 
significantly different between the groups. 
 
Admission temperature following transfer 
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2027 infants (85.7%) transferred from a non-CC to a CC had an admission 
temperature recorded after arrival. Of these, 259 (12.7%) had an admission 
temperature within the optimal therapeutic range of 33.5 +/- 0.5 oC32 before six hours 
of age (Figure 1 and Supplementary Table 2). Overall, 1362 (67.1%) of infants 
arrived at the CC following transfer with an admission temperature within target 
range (Supplementary Table 2). There was no significant difference between time of 
admission for infants who arrived with their temperature within and outside of optimal 
therapeutic range (7 hours 40 minutes vs 7 hours 44 minutes, p=0.77).  Following 
transfer to a level 3 centre, infants born in a level 2 CC were significantly more likely 
to arrive with a temperature in therapeutic range compared to those born in a level 2 
non-CC (78.3% vs 67.4% respectively, OR 0.57; 95% CI 0.43-0.76, p<0.001) and 
were less likely to be over-cooled (<33oC) on arrival (8.1% vs 14.9%, OR 0.51; 95% 
CI 0.34-0.76, P<0.001) (Table 4, Figure 1 and Supplementary Table 3). 
 
DISCUSSION 
In the UK, the management of HIE with active TH remains mostly in centralised 
centres within geographical networks and therefore is not currently available in every 
birthing hospital. This nationwide UK study, of over 5,000 infants with HIE, evaluated 
the relationship between birth in a non-CC and important short-term outcomes using 
propensity-score matched groups. We found almost half of infants were born in non-
CCs and were less likely to survive without seizures at discharge compared to those 
born in CCs. This association appears to be driven by a higher rate of recorded 
seizures in non-CC infants as the mortality rates were similar. Importantly, the 
association remained significant when comparing only infants born in level 2 centres 
and following exclusion of those born at home or midwifery led units. 
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There is increasing evidence that seizures, and the seizure burden relating to HIE, 
can have an additive effect on the initial brain injury, independent of HIE severity.15-17 
22 33 Neonatal seizures occur in 50-60% of infants with HIE34 and are associated with 
an increased risk of adverse neurodevelopment outcome, cerebral palsy and 
epilepsy compared to those without seizures.35 We found fewer recorded seizures in 
those with access to immediate active TH in CCs supporting evidence from several 
smaller studies 21 36 and a systematic review which found a borderline risk reduction 
of seizures.6 There was no increase in the use of anticonvulsants between the 
groups in the main analysis; the subgroup of level 2 non-CC births were exposed to 
more treatment with multiple anticonvulsants, some potentially neurotoxic with 
adverse additive effects on long-term neurodevelopment.37 
 
Specialist neonatal transport teams transferred 53.1% of infants with HIE during the 
study period at a time when many transport services transitioned from mainly 
passive cooling to active, servo-controlled TH.38 Only 12.7% of infants transferred to 
a CC had an admission temperature within the optimal therapeutic range by six 
hours of age. A further 48.3% arrived between 6-12 hours of age in target range. 
There could be delay in deciding to initiate TH in some of the infants which could 
account for those in the normothermic range. Brain injury following hypoxic-
ischaemic injury is progressive consisting of primary, latent and secondary phase.39 
The latent period is considered the optimal time for TH through reduction of cellular 
injury,40 41 although TH commenced within the late latent phase resulted in reduced 
cell survival compared to earlier use.9 Furthermore, TH commenced after the latent 
phase post seizure activity did not improve cell survival.42 It is plausible that these 
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infants only receive partial protection from TH through passive cooling, which is more 
likely to occur during the late latent phase or beyond and result in decreased 
dampening of excitatory neurotransmitters.9 Studies have suggested this reduction in 
excitatory transmitter release, along with alterations in neuronal membrane 
potentials as a result of TH, could contribute to the potential of this treatment to 
directly reduce epileptiform activity, either alone or synergistically with other agents43 
44. This could also support our findings that infants born in a CC with immediate 
access to TH had fewer reported seizures. 
Comparing infants born in level 2 centres, a greater proportion of CC infants arrived 
with a temperature in optimal range compared with non-CC infants, with more over-
cooled in the latter group. Immediate access to active TH not only reduces the risk of 
complications associated with over-cooling or potential lack of neuroprotection due to 
under-cooling, but also mitigates the time critical burden placed on the transport 
team to commence TH within six hours of birth. This could explain the later 
admission time to tertiary CCs of infants born within level 2 centres CCs.  
 
The transport process itself exposes the infant to noxious stimuli which could 
contribute to on-going brain injury.45 Preterm infants transferred in early life have an 
increased risk of brain injury.46 It is unclear if exposure to significant levels of 
vibration and noise during inter-hospital transport, beyond that deemed safe for 
healthy adults, is a contributory mechanism to the additional seizures identified in 
this study.   
 
Strengths and limitations  
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This study is one of the largest population studies in the TH era utilising routinely 
recorded patient data from over 180 centres, overcoming single-centre study 
weakness and allowing variation in management across a national healthcare 
service. The use of robust propensity matching with well-balanced groups is also a 
significant strength, especially as undertaking a clinical trial of this nature may not be 
ethical or feasible. The large dataset has allowed identification of fewer infants 
recorded as having seizures that may not have been possible with smaller studies.   
The main limitation of our study is the use of seizures as a proxy of brain injury due 
to the lack of neuroimaging results or long-term follow-up as these are not 
universally recorded in the NNRD dataset. However, previous work has 
demonstrated an association with seizures, MRI findings and later development.36 47 
Another limitation is the lack of details on seizure diagnostic criteria or alternative 
aetiology, such as hypoglycaemia, fetal and neonatal drug exposure, as these are 
not recorded in sufficient detail within the database. Diagnosis of seizures were 
determined and coded by the attending clinical team and could be either clinical or 
electrical in nature. We did try to mitigate this by reporting the use of anticonvulsant 
therapy.  
We could not account for differences in antenatal or neonatal care within the model 
which may be different between non-CCs and CCs, although sub-analysis of level 2 
births only minimised bias due to variation in clinical practice. Criteria for TH in 
infants with HIE are clearly defined by national guidance 32 but the database had 
significant numbers of missing data such as 10 minute Apgar and cord/admission pH 
values. We therefore assumed if the diagnostic classification was recorded and an 
infant underwent TH they met the criteria for treatment. We also acknowledge the 
database does not allow differentiation of equipment used by transport teams nor the 
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exact time that target temperatures are achieved, which could be before admission 
to the CC.   
 
CONCLUSION 
This study demonstrates that almost half of infants with moderate/severe HIE in the 
UK are born in non-CCs and are less likely to have seizure-free survival compared to 
infants born in CCs, even when comparing level 2 centre births only. Furthermore, 
many infants transferred to CCs have admission temperatures outside the optimal 
TH time and temperature windows. The disparity of immediate access to active TH, 
a treatment known to reduce mortality and disability, could delay optimal therapy and 
impact on outcomes. With the increasing recognition of the relative safety of TH,6 
consideration should be given for training, equipping and supporting non-CCs with 
active TH, minimising delays in initiating and achieving optimal target temperature 
prior to upward transfer to a specialised CC. Further work is also required to explore 
any potential adverse effects of inter-hospital transport on infants at risk of brain 
injury and suitable mitigation strategies. 
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What is already known on this topic –  
 Hypoxic ischaemic encephalopathy (HIE) remains the leading cause of 
mortality and neurodisability in term infants 
 Active therapeutic hypothermia commenced within the first six hours post 
hypoxic insult is safe and significantly improves survival and severe 
neurodisability 
 Infants who subsequently develop seizures secondary to HIE have worse 
neurodevelopmental outcomes, independent of HIE severity 
 
What this study adds –  
 Infants with moderate or severe HIE who are born in centres without 
immediate access to active therapeutic hypothermia are less likely to survive 
without seizures 
 Infants who are transferred into cooling centres frequently arrive beyond the 
optimal six hour therapeutic window and with temperatures outside of 
treatment range. 
 Infants transferred to tertiary cooling centres from level 2 centres with active 
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Table 1. Demographic and clinical variables of infants 36 weeks gestational age with moderate or severe hypoxic ischaemic 
encephalopathy both pre- and post-propensity score-matching 
 Unmatched infants Propensity score-matched infants 
Variables Born in non-CC 
n=2364a 





Born in non-CC 
n=2165a 





Gender (Male) 1354 (57.3) 1417 (52.6) -0.095 0.002 1203 (55.6) 1225 (56.6) 0.020 0.49 










Gestation (weeks) 40 (38-41) 40 (38-41) -0.015 0.47 40 (38-41) 40 (38-41) -0.006 0.85 










Pre-eclampsia 113 (4.8) 120 (4.5) 0.016 0.58 98 (4.5) 97 (4.5) 0.003 0.92 
Maternal infection 555 (23.5) 559 (20.7) 0.066 0.02 480 (22.2) 480 (22.2) 0.000 0.99 
Mode of deliveryc 
  Em CS no labour 
  Em CS in labour 
  El CS no labour 
  El CS in labour 
  Instrumental 


























































  Cephalic 
  Breech 
  Transverse 
  Other 

















































Intra-partum events 276 (11.7) 349 (13.0) -0.039 0.17 265 (12.2) 257 (11.9) 0.011 0.72 
Significant 
resuscitation 
1364 (57.7) 1703 (63.2) -0.112 <0.001 1312 (60.6) 1278 (59.0) 0.033 0.28 
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Table 1. (continued) 










Born in non-CC 
n=2165a 





Apgar at 5 minutes 4 (2-5) 4 (2-6) -0.010 0.56 4 (2-5) 4 (2-6) -0.003 0.72 
Grade of HIE 
  Grade 2 





















Place of birth leveld 
  Level 1 
  Level 2 
  Level 3 
  Home 

















































  L1-L3 Transfer 

























CC, Cooling Centre; SMD, Standardised mean difference; NVD, Normal vaginal delivery; Em CS, Emergency caesarean section; El CS, Elective caesarean 
section; HIE, Hypoxic Ischaemic encephalopathy; L2, level 2; L3, Level 3 
a Data are n (%) or median (interquartile range). 
b Categorical data analysed using chi squared test; non normally distributed continuous data analysed using Mann-Whitney U test; matched data by paired t-
test for continuous data or McNemar’s test or extensions thereof for binary and categorical data  
c Compared to baseline – NVD 
d Variables not included in propensity score matching 
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Table 2. Outcomes of infants with moderate or severe hypoxic ischaemic 
encephalopathy who were born in either a non-cooling or cooling centre after 
propensity score matching 
Outcome variable 
Born in non-CC 
n = 2165a 
Born in CC 
n = 2165a 




Survival without seizures 693 (31.8) 764 (35.1) 1.15 (1.02-1.31) 0.02 
Seizures 1399 (64.6) 1314 (60.7) 0.84 (0.75-0.95) 0.007 
Death 312 (14.4) 343 (15.8) 1.11 (0.93-1.31) 0.20 
Day of death (Hours) 
  < 24  
  24 -72 

















  None 
  1 drug 


















  Ventilated 
  HFOV 

















Hypotension 983 (45.4) 982 (45.4) 0.99 (0.88-1.12) 0.96 
PPHN 260 (12.0) 236 (10.9) 0.90 (0.74-1.08) 0.25 
Nitric Oxide 214 (9.9) 236 (10.1) 1.02 (0.84-1.25) 0.79 
Length of stay (days) 11.3 (7.3-18.9) 10.0 (6.5-16.4) 0.14 (0.05-0.36) <0.001 
CC, Cooling Centre, 95% CI, 95% Confidence interval, HFOV, High Frequency Oscillatory Ventilation; 
CPAP, Continuous positive airway pressure; PPHN, Persistent pulmonary Hypertension;  
a Data are n (%) or median (interquartile range) 
b Compared to baseline – No anticonvulsant/No respiratory support 










Table 3. Demographic and clinical variables of infants with moderate or severe hypoxic ischaemic encephalopathy born in level 2 centres post 
propensity score-matching 
 Unmatched infants Propensity score matched infants 
Variables 
Born in non-CC 
n = 1546a 
Born in CC 




Born in non-CC 
n = 696a 
Born in CC 




Gender (Male) 877 (56.7) 373 (53.2) -0.070 0.12 366 (52.6) 373 (53.6) 0.020 0.71 






(3004 – 3764) 
3370  
(2953 – 3730) 
0.036 0.50 
Gestation (weeks) 40 (38–41) 40 (38-41) -0.047 0.28 40 (39–41) 40 (38–41) 0.032 0.56 










Pre-eclampsia 71 (4.6) 38 (5.4) -0.040 0.40 31 (4.5) 38 (5.5) -0.046 0.39 
Maternal Infection 383 (24.8) 173 (24.7) 0.002 0.96 176 (25.3) 172 (24.7) 0.013 0.80 
Mode of deliveryc: 
   Em CS no labour 
   Em CS in labour  
   El CS no labour 
   El CS in labour 
   Instrumental 


























































   Cephalic 
   Breech 
   Transverse lie 
   Other 

















































Intra-partum events 187 (12.1) 89 (12.7) -0.018 0.69 93 (13.4) 89 (12.8) 0.017 0.75 
Significant 
Resuscitation 
935 (60.50 434 (61.9) -0.029 0.52 440 (63.2) 432 (62.1) 0.023 0.66 
Apgar at 5 minutes 4 (2-5) 4 (2-6) -0.070 0.09 4 (3 – 6) 4 (2 – 6) 0.018 0.74 
Grade of HIE 
   Grade 2 





















CC, Cooling centre; SMD, Standardised Mean Difference; NVD, Normal vaginal delivery; Em CS, Emergency caesarean section; El CS, Elective caesarean section; HIE, 
Hypoxic Ischaemic Encephalopathy 
a Data are n (%) or median (interquartile) 
b Categorical data analysed using chi squared test; non normally distributed continuous data analysed using Mann-Whitney U test; matched data by paired t-test for 
continuous data or McNemar’s test or extensions thereof for binary and categorical data 
c Compared to baseline - Normal Vaginal delivery
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Table 4. Outcomes of infants with moderate or severe hypoxic ischaemic encephalopathy 
who were born in either a level 2 non-cooling or cooling centre after propensity score-
matching 
Outcome variable 
Born in non-CC 
n = 696a 
Born in CC 





Survival without seizures 225 (32.3) 270 (38.8) 1.33 (1.06-1.65) 0.01 
Seizures 445 (63.9) 401 (57.6) 0.77 (0.61-0.95) 0.02 
Death 105 (15.1) 90 (12.9) 0.84 (0.62-1.13) 0.25 
Day of death (Hours) 
  <= 24  
  24 -72 
  > 72 
 
















  None 
  1 drug 


















  Ventilated 
  HFOV 

















Hypotension 326 (46.8) 303 (43.5) 0.88 (0.71-1.08) 0.22 
PPHN 97 (13.9) 95 (13.8) 0.98 (0.72-1.32) 0.88 
Nitric Oxide 66 (9.5) 67 (9.6) 1.01 (0.71-1.45) 0.93 
Transferred L2-L3 615 (88.4) 449 (64.5) 0.24 (0.18-0.32) <0.001 
Length of stay (days) 10.6 (7.0-17.5) 10.5 (6.8-17.7) 0.55 (0.13-2.40) 0.41 
CC, Cooling Centre; 95% CI, 95% Confidence Interval; HFOV, High Frequency Oscillatory Ventilation; 
CPAP, Continuous positive airway pressure; PPHN, Persistent pulmonary Hypertension;  
a Data are n (%) 
b Compared to baseline - No anticonvulsants/No respiratory support 






Figure 1. Admission temperature and arrival time following transfer to a cooling centre of 
infants 36 weeks gestational age with moderate or severe HIE a) who were born in a 
non-cooling hospital (n=2027) (shaded area optimal temperature in the six hour optimal 
therapeutic window), b) who were born level 2 centres with immediate access to active TH 
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Supplementary Figure 2 Propensity score distribution (A) and 
Standardised Bias (B) for infants born in non-cooling centres (control) and 




Supplementary Figure 3 Propensity score distribution (A) and 
Standardised Bias (B) for infants born in level 2 non-cooling centres (control) 
and those born in cooling centres (treated) both before and after propensity 
score matching 
 
Supplementary Figure 4 Propensity score distribution (A) and 
Standardised Bias (B) between infants born in a non-cooling centre (control) 
and those born in a cooling centre (treated) both before and after propensity 
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Supplementary Table 1. Description of data fields used for determining covariates and 
outcomes from the National Neonatal Research Database  
 
Principle Diagnosis at Discharge database entries for HIE Grading 
Severe HIE: 
 
- HIE Grade 3 - Severe Neonatal Encephalopathy 
- Hypoxic ischaemic brain damage ; Severe 
- Severe perinatal asphyxia (with 1 minute Apgar <4) 
- Severe Neonatal Encephalopathy - Gr.3 
- Hypoxic Ischaemic Encephalopathy (Gr 3) 




- HIE Grade 2 - Moderate Neonatal Encephalopathy 
- Hypoxic ischaemic brain damage ; Moderate 
- Moderate perinatal asphyxia (with 1 minute Apgar 4-7) 
- Moderate Neonatal Encephalopathy - Gr.2 
- Hypoxic Ischaemic Encephalopathy (Gr 2) 




- HIE Grade 1 - Mild Neonatal Encephalopathy 
- Hypoxic ischaemic brain damage ; Mild 
- Mild perinatal asphyxia (with 1 minute Apgar >7) 
- Mild Neonatal Encephalopathy - Gr.1 
- Hypoxic Ischaemic Encephalopathy (Gr 1) 
- Mild Neonatal Encephalopathy - Grade 1 HIE 




- Birth Asphyxia 




- Therapeutic Hypothermia 
- Therapeutic Hypothermia (whole body cooling) 
- Hypothermia Therapeutic 




- Therapeutic Hypothermia 
- Therapeutic Hypothermia (whole body cooling) 
- Hypothermia Therapeutic 
 




- Gestation in weeks 
- Year of Birth 
- Onset of Labour 
- Presentation of fetus 
- Mode of Delivery 
- Methods of resuscitation 
- Apgar score at 5 minutes 
- Nulliparity determined from data field “Number of previous pregnancies” 
- Meconium stained liquor 
- Maternal Infection determined from data fields “Maternal pyrexia in labour” 
and “Problems during pregnancy with mother” (maternal UTI 
/chorioamnionitis/prolonged rupture of membranes) 
- Hypotension determined from data fields “Inotropes given”, “Daily drugs”, 
“Principal diagnosis at discharge” 
- Place of birth NHS hospital code 
- Place of birth NHS hospital level 
- Nitric oxide determined from data fields “Pulmonary vasodilator” and 
“Principle diagnosis at discharge” 
- Persistent pulmonary hypotension determined from data fields “Principle 
diagnosis at discharge”  
- Pre-eclampsia determined from data field problems during pregnancy with 
mother 
- Gestational Diabetes determined from data field “Problems during 
pregnancy with mother” 
- Acute intrapartum events determined from data fields “Problems (obstetric) 
during pregnancy with mother” (Reduced fetal movements/placental 
abruption/cord problems/shoulder dystocia) and “Principle diagnosis on 
discharge”  
- Significant resuscitation determined from data field “Methods of 
resuscitation” (cardiac compressions/intubation/adrenaline/other drugs) 
- Respiratory Support device (No support/CPAP/Ventilated/HFOV) 
 
Outcome Variables 
- Death determined from Destination at Discharge data field. If an infant was 
discharge “home”, “ward” or “Foster Care” the infants was coded as 
surviving.  
- Seizures determined from “Convulsions today” and “Principle diagnosis at 
discharge data fields”. Infants were also coded as having seizures if they 
received anticonvulsants in the “Daily Drugs” data field. 
- Number of anticonvulsants determined from “Daily Drugs” data field 
- Admission temperature 
- Time of admission temperature 
- Admission time to neonatal unit 
- Length of stay determined from Admission time and Time of discharge data 
fields 
HIE, Hypoxic Ischaemic Encephalopathy; UTI, Urinary Tract Infection; NHS, National Health Service; CPAP, 






Propensity Score Matching 
Propensity score analysis entailed fitting a logistic regression model using a stepwise 
process and evaluation of potential interactions to determine variables to include in the 
propensity score. For variables with missing data values were either imputed using Markov 
chain Monte Carlo method (1) or a separate category was defined indicating non-
response. Initially, a priori background variables (gender, gestation, birthweight and birth 
year) were selected for inclusion into the logistic regression model regardless of their 
statistical association with the outcome. This baseline model was fitted with addition of one 
other background variable at a time. The variable with the greatest t ratio was included in 
the model if >1.0. This process was repeated, until t ratios for all remaining variables were 
smaller than 1.0. Following this analysis 13 covariates were included. These were: 
- Gender 
- Birthweight 
- Gestation in weeks 
- Birth year 
- Nulliparity 
- Pre-eclampsia 
- Maternal infection 
- Mode of delivery 
- Presentation at birth 
- Acute intrapartum events 
- Significant resuscitation at birth 
- Apgar score at 5 minutes 
- Grade of HIE 
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Interactions 
Interactions were determined for inclusion into model by ranking the variables in the 
concluding model by their t ratio and expanding this model by one second-order term at a 
time. The interaction term was included in the model if t ratio was greater than 2.71, which 
corresponds to nominal statistical significance at 10% level. No interactions reached this 
level in our analysis (2).  
 
Propensity scores were estimated using logistic regression based on the selected 
background variables. A matched sample of untreated and treated infants was created 
through matching on the logit of the propensity score with caliper width set at 0.05. The 
propensity strata were trimmed by excluding infants with extreme propensities to minimise 
residual confounding. A nearest neighbour 1:1 matching algorithm with no replacement 
was used to form pairs of infants in the CC and non-CC group (3). 
 
Assessment of balance 
The matching process was evaluated by division of the propensity score into an optimal 
number of blocks and assessing the within-block equality of means of covariates across 
the treatment groups. The propensity distribution density was evaluated between control 
and treated groups both pre and post matching. (Supplementary Figure 2). Additionally, 
standardised percentage bias for each covariate (formulae as detailed by Rosenbaum and 
Rubin) after matching was calculated. A covariate was considered balanced if the 
standardised differences were between -0.2 and 0.2 and standardised mean bias was 
<5% (4) (5)(Supplementary Figure 2). The resulting model was well balanced with no 
covariate with a mean bias of >5% and overall mean bias 1.7 with no significant difference 




Sensitivity analyses were performed between infants born in level 2 non-cooling and 
cooling centres and between infants born in non-cooling and cooling centres but excluding 
infants born at home and midwife led units to mitigate potential bias. Further propensity 
score matching and assessment of balance was undertaken using the above described 
methodology for these subgroups of infants. Evaluation of model balance is demonstrated 
in Supplementary Figure 3 and 4. 
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Supplementary Figure 1. Flowchart of study participants demonstrating the number 
of infants 36 weeks gestational age with moderate or severe hypoxic ischaemic 




GA, Gestational age; m/s HIE, moderate or severe hypoxic ischaemic encephalopathy; TH, 






Supplementary Figure 2. Propensity score distribution (A) and Standardised Bias 
(B) for infants born in non-cooling centres (control) and those born in cooling centres 
(treated) both before and after propensity score-matching 
 
 
EmLSCS, Emergency caesarean section; ElLSCS, Elective caesarean section; APGAR, Appearance, 






Supplementary Figure 3. Propensity score distribution (A) and Standardised Bias 
(B) for infants born in level 2 non-cooling centres (control) and those born in cooling 
centres (treated) both before and after propensity score matching 
 
 
EmLSCS, Emergency caesarean section; ElLSCS, Elective caesarean section; APGAR, Appearance, 
Pulse, Grimace, Activity and Respiration score; HIE, Hypoxic ischaemic encephalopathy 
 
 
Supplementary Figure 4. Propensity score distribution (A) and Standardised Bias 
(B) between infants born in a non-cooling centre (control) and those born in a cooling 
centre (treated) both before and after propensity score-matching excluding those 
born at home or in midwife led units 
 
 
EmLSCS, Emergency caesarean section; ElLSCS, Elective caesarean section; APGAR, Appearance, 
Pulse, Grimace, Activity and Respiration score; HIE, Hypoxic ischaemic encephalopathy 
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Supplementary Table 2. Admission temperature and arrival time following transfer 
to a cooling centre of infants 36 weeks gestational age with moderate or severe HIE 

















Supplementary Table 3. Admission temperature and arrival time following transfer 
to a level 3 cooling centre for infants 36 weeks gestational age with moderate or 
severe HIE who were born level 2 centres with immediate access to active 
therapeutic hypothermia or non-cooling centre. 
 
 
  Age at Admission 
  Non-cooling centre 
(n = 611) 
Cooling centre 
(n = 443) 
  < 6 
Hours 

















 > 34oC 3.6 
(n = 22) 
11.6 
(n = 71) 
2.5 
(n = 15) 
1.1 
(n = 5) 
8.1 
(n = 36) 
4.3 
(n = 19) 
33-34oC 12.9 
(n = 79) 
49.3 
(n = 301) 
5.2 
(n = 32) 
9.9 
(n = 44) 
55.3 
(n = 245) 
13.1 
(n = 58) 
<33oC 2.3 
(n = 14) 
11.9 
(n = 73) 
0.7 
(n = 4) 
1.1 
(n = 5) 
4.7 
(n = 21) 
2.3 
(n = 10) 
  Age at Admission 












(n = 86) 
11.9% 
(n = 242) 
2.4% 
(n = 48) 
33-34oC 
12.7% 
(n = 259) 
48.3% 
(n = 979) 
6.1% 
(n = 124) 
<33oC 
2.5% 
(n = 52) 
10.3% 
(n = 209) 
1.3% 
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